These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

240 related items for PubMed ID: 21545619

  • 1. Combined pharmacogenetic effect of ADCY9 and ADRB2 gene polymorphisms on the bronchodilator response to inhaled combination therapy.
    Kim SH, Ye YM, Lee HY, Sin HJ, Park HS.
    J Clin Pharm Ther; 2011 Jun; 36(3):399-405. PubMed ID: 21545619
    [Abstract] [Full Text] [Related]

  • 2. Pharmacogenetic study of the effects of NK2R G231E G>A and TBX21 H33Q C>G polymorphisms on asthma control with inhaled corticosteroid treatment.
    Ye YM, Lee HY, Kim SH, Jee YK, Lee SK, Lee SH, Park HS.
    J Clin Pharm Ther; 2009 Dec; 34(6):693-701. PubMed ID: 20175803
    [Abstract] [Full Text] [Related]

  • 3. Treatment of persistent asthma with Symbicort (budesonide/formoterol inhalation aerosol): an inhaled corticosteroid and long-acting beta2-adrenergic agonist in one pressurized metered-dose inhaler.
    Berger WE, Noonan MJ.
    J Asthma; 2010 May; 47(4):447-59. PubMed ID: 20528601
    [Abstract] [Full Text] [Related]

  • 4. Effect of inhaled formoterol and budesonide on exacerbations of asthma. Formoterol and Corticosteroids Establishing Therapy (FACET) International Study Group.
    Pauwels RA, Löfdahl CG, Postma DS, Tattersfield AE, O'Byrne P, Barnes PJ, Ullman A.
    N Engl J Med; 1997 Nov 13; 337(20):1405-11. PubMed ID: 9358137
    [Abstract] [Full Text] [Related]

  • 5. Effect of ADRB2 polymorphisms on response to longacting beta2-agonist therapy: a pharmacogenetic analysis of two randomised studies.
    Bleecker ER, Postma DS, Lawrance RM, Meyers DA, Ambrose HJ, Goldman M.
    Lancet; 2007 Dec 22; 370(9605):2118-25. PubMed ID: 18156033
    [Abstract] [Full Text] [Related]

  • 6. Fluticasone/formoterol combination therapy versus budesonide/formoterol for the treatment of asthma: a randomized, controlled, non-inferiority trial of efficacy and safety.
    Bodzenta-Lukaszyk A, Buhl R, Balint B, Lomax M, Spooner K, Dissanayake S.
    J Asthma; 2012 Dec 22; 49(10):1060-70. PubMed ID: 23102189
    [Abstract] [Full Text] [Related]

  • 7. The use of inhaled formoterol in the treatment of asthma.
    Berger WE.
    Ann Allergy Asthma Immunol; 2006 Jul 22; 97(1):24-33. PubMed ID: 16892777
    [Abstract] [Full Text] [Related]

  • 8. Efficacy of budesonide/formoterol pressurized metered-dose inhaler versus budesonide pressurized metered-dose inhaler alone in Hispanic adults and adolescents with asthma: a randomized, controlled trial.
    Zangrilli J, Mansfield LE, Uryniak T, O'Brien CD.
    Ann Allergy Asthma Immunol; 2011 Sep 22; 107(3):258-65.e2. PubMed ID: 21875546
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Inhaled steroid/long-acting beta 2 agonist combination products provide 24 hours improvement in lung function in adult asthmatic patients.
    Lötvall J, Langley S, Woodcock A.
    Respir Res; 2006 Aug 18; 7(1):110. PubMed ID: 16919161
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Bronchodilator response in relation to beta2-adrenoceptor haplotype in patients with asthma.
    Taylor DR, Epton MJ, Kennedy MA, Smith AD, Iles S, Miller AL, Littlejohn MD, Cowan JO, Hewitt T, Swanney MP, Brassett KP, Herbison GP.
    Am J Respir Crit Care Med; 2005 Sep 15; 172(6):700-3. PubMed ID: 15976384
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Efficacy and safety of high-dose budesonide/formoterol (Symbicort) compared with budesonide administered either concomitantly with formoterol or alone in patients with persistent symptomatic asthma.
    Jenkins C, Kolarikova R, Kuna P, Caillaud D, Sanchis J, Popp W, Pettersson E.
    Respirology; 2006 May 15; 11(3):276-86. PubMed ID: 16635085
    [Abstract] [Full Text] [Related]

  • 19. Effect of formoterol with or without budesonide in repeated low-dose allergen challenge.
    Dahlén B, Lantz AS, Ihre E, Skedinger M, Henriksson E, Jörgensen L, Ekström T, Dahlén SE, Larsson K.
    Eur Respir J; 2009 Apr 15; 33(4):747-53. PubMed ID: 19129280
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.